Cargando...
Interleukin-17 promotes the development of cisplatin resistance in colorectal cancer
Cisplatin (DDP)-based anticancer therapy is an important chemotherapeutic strategy for the treatment of colorectal cancer. However, its beneficial effect is largely compromised by adverse reactions, and more importantly, by the development of drug resistance. Therefore, it is crucial to determine th...
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313016/ https://ncbi.nlm.nih.gov/pubmed/30655852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9645 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|